Samuel GaryLuskMD(He/Him)

Child & Adolescent Psychiatry, Neuropsychiatry, Psychopharmacology

Austin Neurobehavioral Medicine

Dr. Lusk is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
12300 Torrance Court
Austin, TX 78738
Phone+1 512-306-0002

Fax+1 877-992-8563

University of Texas Health Science Center at HoustonResidency, Psychiatry, 1986 - 1990
University of Texas Health Science Center at HoustonInternship, Psychiatry, 1986 - 1987
McGovern Medical School at UTHealthClass of 1986

Teaching Excellence Medical Students/House Staff, 1989-1990
Master Psychopharmacologist Program 2004/2010 Neuroscience Education Institute, 2000
Roger McCary Award for Physician Excellence Seton Shoal Creek Hospital, 1998

Lectures

Numerous regarding mood, anxiety, schizophrenia and therapeutic psychopharmacology
Various from 1994-2012

Other

Guidelines for Antidepressant Use (for Pharmacy and Therapeutics Committee at Austin Regional Clinic 1991)
Samuel Gary Lusk, MD, Various
Austin,Texas - 1/1/1991

Chief, Seton Hospital Department of Psychiatry 1999 - 2000
President of Medical Staff and Medical Executive Committee, Seton Shoal Creek Hospital 1998 - 2000
Member, Seton Hospital Board of Directors 1998 - 2000
Member, Board of Directors, Austin Regional Clinic 1996 - 2000
Director, Child and Adolescent Outpatient Services 1996 - 2000
Chief, Peer Review Committee, Seton Shoal Creek Hospital 1995 - 1997
Member and Vice President, Seton Shoal Creek Hospital, Medical Executive Committee 1994 - 2000
Member, Austin Regional Clinic Department of Behavioral Health Management Team 1994 - 2000
Director, Austin Regional Clinic Attention Deficit Hyperactivity Disorder Clinic 1994 - 2000
Chief, Pharmacy and Therapeutics Committee 1990 - 1993

Research Associate/House StaffInterview of patient participants and completion of rating scales in the assessment of efficacy of desipramine in panic disorder1989 - 1990

Member Advisory Board, Pfizer Pharmaceuticals, Eli Lilly, Solvay,Shire, Forest,Wyeth, Glaxo Smith Kline , Abbot Labs, CephalonParticipated in class education regarding new medications, advising commercial staff, and giving lectures to healthcare professionalsDisclosure: Speaking and industry participation was discontinued in 20121994 - 2012